Fresenius SE & Co. KGaA Logo

Fresenius SE & Co. KGaA

ISIN

DE0005785604

Ticker

FRE

Sector

Health Care

Sub-Industry

Health Care Facilities

Country

Germany

Year Founded

1912

About Fresenius SE & Co. KGaA

Company Description

Fresenius is a global healthcare group offering high-quality products and services for dialysis, hospitals, and outpatient treatment. With over 300,000 employees in more than 100 countries around the globe, and annual sales exceeding €35 billion, Fresenius is one of the world’s leading healthcare companies.

Headcount

311,269

Served Area

Worldwide

Headquarters

Else-Kröner-Straße 1
61352, Bad Homburg v. d. Höhe
Germany

Filings & Publications

  • Consolidated Report 2022 - Q1 German 🇩🇪
  • Consolidated Report 2022 - Q1 English 🇬🇧
  • Company Presentation 2022 - Q1 English 🇬🇧
  • Consolidated Report 2022 - Q2 English 🇬🇧
  • Company Presentation 2022 - Q2 English 🇬🇧
  • Consolidated Report 2022 - Q3 English 🇬🇧
  • Company Presentation 2022 - Q3 English 🇬🇧
  • Consolidated Report 2022 - Q4 English 🇬🇧
  • Company Presentation 2022 - Q4 English 🇬🇧
  • Consolidated Report 2021 - Q1 English 🇬🇧
  • Consolidated Report 2021 - Q1 German 🇩🇪
  • Consolidated Report 2021 - Q2 German 🇩🇪
  • Consolidated Report 2021 - Q2 English 🇬🇧
  • Consolidated Report 2021 - Q3 German 🇩🇪
  • Consolidated Report 2021 - Q3 English 🇬🇧
  • Consolidated Report 2021 - Q4 English 🇬🇧
  • Consolidated Report 2020 - Q1 English 🇬🇧
  • Consolidated Report 2020 - Q1 German 🇩🇪
  • Consolidated Report 2020 - Q2 English 🇬🇧
  • Consolidated Report 2020 - Q2 German 🇩🇪
  • Consolidated Report 2020 - Q3 German 🇩🇪
  • Consolidated Report 2020 - Q3 English 🇬🇧
  • Consolidated Report 2020 - Q4 English 🇬🇧
  • Consolidated Report 2019 - Q1 English 🇬🇧
  • Consolidated Report 2019 - Q1 German 🇩🇪
  • Consolidated Report 2019 - Q2 English 🇬🇧
  • Consolidated Report 2019 - Q2 German 🇩🇪
  • Consolidated Report 2019 - Q3 German 🇩🇪
  • Consolidated Report 2019 - Q3 English 🇬🇧
  • Consolidated Report 2019 - Q4 German 🇩🇪
  • Consolidated Report 2019 - Q4 English 🇬🇧
  • Consolidated Report 2018 - Q3 German 🇩🇪
  • Consolidated Report 2018 - Q3 English 🇬🇧
  • Consolidated Report 2018 - Q4 English 🇬🇧
  • Consolidated Report 2018 - Q4 German 🇩🇪
  • Company Presentation 2023 - Q1 English 🇬🇧

Insider Trades

Date Trading entity / Person Association Trade type Volume
04.08.2023 Moser, Dr. Michael Board Buy EUR 300,565.98
03.04.2023 Sen, Michael Board Buy EUR 586,989.25
03.04.2023 Hennicken, Sara Board Buy EUR 49,839.92
18.11.2022 De Meo, Dr. Francesco Board Buy EUR 50,415.29
29.08.2022 De Meo, Dr. Francesco Board Sell EUR 50,831.20
05.08.2022 Sturm, Stephan Board Buy EUR 119,831.44
05.08.2022 Sturm, Stephan Board Buy EUR 119,676.59
05.08.2022 Schmitt, Martin Board Buy EUR 5,150.00
10.06.2022 Sturm, Stephan Board Other EUR 54,089.64
10.06.2022 Kirsch, Wolfgang Supervisory board Other EUR 6,901.09

Capital Markets Information

ISIN

DE0005785604

LEI

XDFJ0CYCOO1FXRFTQS51

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

DAX

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.